Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E D Bateman

Showing results (31-40 of 111) with videos related to

Pageof 12
Sort By:
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|April 19, 2007
Asthma--is survival good enough?R J Green, H J Zar, E D Bateman
Anaesthesia and Intensive Care|November 1, 1992
Bilateral phrenic nerve palsy following cardiac surgery in a diabetic patientP C Gordon, E D Bateman, D M Linton
The European Respiratory Journal|October 3, 2002
Achieving guideline-based asthma control: does the patient benefit?E D Bateman, L F Frith, G L Braunstein
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|February 11, 1984
Cryptogenic fibrosing alveolitis. Clinical spectrum and treatmentS J Louw, E D Bateman, S R Benatar
Allergy|February 15, 2007
Keeping allergy on the agenda: integrated guidelines for respiratory disease in developing countriesR G English, L R Fairall, E D Bateman
Respiratory Research|January 26, 2006
Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamolE D Bateman, L Fairall, D M Lombardi, et al.
Public Health Action|September 23, 2015
The new epidemic of non-communicable disease in people living with the human immunodeficiency virusR Dawson, W N Rom, K Dheda, et al.
Thorax|September 1, 1981
Immunohistochemical study of collagen types in human foetal lung and fibrotic lung diseaseE D Bateman, M Turner-Warwick, B C Adelmann-Grill
Respiratory Medicine|August 11, 2007
Initiation of maintenance treatment with salmeterol/fluticasone propionate 50/100 microg bd versus fluticasone propionate 100 microg bd alone in patients with persistent asthma: integrated analysis of four randomised trialsN C Barnes, L Jacques, C Goldfrad, et al.
The European Respiratory Journal|April 1, 1995
High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study GroupJ G Ayres, E D Bateman, B Lundbäck, et al.
Pageof 12

Showing results (31-40 of 111) with videos related to

Sort By:
Pageof 12
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|April 19, 2007
Asthma--is survival good enough?R J Green, H J Zar, E D Bateman
Anaesthesia and Intensive Care|November 1, 1992
Bilateral phrenic nerve palsy following cardiac surgery in a diabetic patientP C Gordon, E D Bateman, D M Linton
The European Respiratory Journal|October 3, 2002
Achieving guideline-based asthma control: does the patient benefit?E D Bateman, L F Frith, G L Braunstein
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|February 11, 1984
Cryptogenic fibrosing alveolitis. Clinical spectrum and treatmentS J Louw, E D Bateman, S R Benatar
Allergy|February 15, 2007
Keeping allergy on the agenda: integrated guidelines for respiratory disease in developing countriesR G English, L R Fairall, E D Bateman
Respiratory Research|January 26, 2006
Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamolE D Bateman, L Fairall, D M Lombardi, et al.
Public Health Action|September 23, 2015
The new epidemic of non-communicable disease in people living with the human immunodeficiency virusR Dawson, W N Rom, K Dheda, et al.
Thorax|September 1, 1981
Immunohistochemical study of collagen types in human foetal lung and fibrotic lung diseaseE D Bateman, M Turner-Warwick, B C Adelmann-Grill
Respiratory Medicine|August 11, 2007
Initiation of maintenance treatment with salmeterol/fluticasone propionate 50/100 microg bd versus fluticasone propionate 100 microg bd alone in patients with persistent asthma: integrated analysis of four randomised trialsN C Barnes, L Jacques, C Goldfrad, et al.
The European Respiratory Journal|April 1, 1995
High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study GroupJ G Ayres, E D Bateman, B Lundbäck, et al.
Pageof 12